ABHD6 Inhibition After Brain Injury Improved Several Outcomes in Mice Without Testing THC Treatment
Post-injury treatment with the ABHD6 inhibitor WWL70 improved motor, memory and tissue outcomes in a mouse traumatic-brain-injury model. The study investigated endogenous 2-AG signaling, rather than administering THC or testing marijuana as a treatment.
A different breakdown enzyme was the intervention target
ABHD6 contributes a smaller portion of 2-AG hydrolysis than monoacylglycerol lipase. The study examined whether modulating this enzyme could produce useful effects after injury. Relative enzyme contribution alone does not establish a therapeutic window; the behavioral and tissue outcomes provide additional, separately relevant evidence.
Functional and structural outcomes both changed
The abstract reported improved motor coordination and working memory, reduced cortical lesion volume and reduced neurodegeneration in another brain region. Blood-brain barrier dysfunction was also reduced at the reported post-injury time points. These outcomes should be named separately rather than collapsed into complete neurological recovery or proof that every function returned to baseline.
Mechanistic markers supported a proposed pathway
The investigators reported changes in inflammatory markers, cannabinoid receptors and signaling proteins. These observations informed an anti-inflammatory and neuroprotective interpretation. Marker changes do not by themselves establish the same mechanism in human injury or prove that a different cannabinoid intervention would reproduce the findings.
Interpreting the evidence
The work provides preclinical evidence for an enzyme-directed strategy given after experimental injury. It does not establish human clinical benefit, an appropriate treatment dose or the safety of using cannabis after a concussion.
Related reading: cell-specific cannabinoid mechanisms and brain-injury interpretation.
Research reference
Tchantchou F; Zhang Y (2013). Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. Journal of neurotrauma. doi:10.1089/neu.2012.2647. Evidence basis: study abstract.
